These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36657855)

  • 21. Isoniazid-loaded chitosan/carbon nanotubes microspheres promote secondary wound healing of bone tuberculosis.
    Chen G; Wu Y; Yu D; Li R; Luo W; Ma G; Zhang C
    J Biomater Appl; 2019 Feb; 33(7):989-996. PubMed ID: 30509120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective disposal of methylene blue using green immobilized silver nanoparticles on graphene oxide and reduced graphene oxide sheets through one-pot synthesis.
    Aboelfetoh EF; Gemeay AH; El-Sharkawy RG
    Environ Monit Assess; 2020 May; 192(6):355. PubMed ID: 32394116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
    Colangeli R; Jedrey H; Kim S; Connell R; Ma S; Chippada Venkata UD; Chakravorty S; Gupta A; Sizemore EE; Diem L; Sherman DR; Okwera A; Dietze R; Boom WH; Johnson JL; Mac Kenzie WR; Alland D;
    N Engl J Med; 2018 Aug; 379(9):823-833. PubMed ID: 30157391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial, anticoagulant and cytotoxic evaluation of biocompatible nanocomposite of chitosan loaded green synthesized bioinspired silver nanoparticles.
    Asghar MA; Yousuf RI; Shoaib MH; Asghar MA
    Int J Biol Macromol; 2020 Oct; 160():934-943. PubMed ID: 32470586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
    Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
    J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.
    Clemens DL; Lee BY; Xue M; Thomas CR; Meng H; Ferris D; Nel AE; Zink JI; Horwitz MA
    Antimicrob Agents Chemother; 2012 May; 56(5):2535-45. PubMed ID: 22354311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis.
    Bunalema L; Fotso GW; Waako P; Tabuti J; Yeboah SO
    BMC Complement Altern Med; 2017 Feb; 17(1):89. PubMed ID: 28148252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents.
    Singh R; Nawale L; Arkile M; Wadhwani S; Shedbalkar U; Chopade S; Sarkar D; Chopade BA
    Int J Nanomedicine; 2016; 11():1889-97. PubMed ID: 27217751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the Antibacterial Activity and Mode of Action of Thymol-Loaded Chitosan Nanoparticles Against Plant Bacterial Pathogen
    Sreelatha S; Kumar N; Yin TS; Rajani S
    Front Microbiol; 2021; 12():792737. PubMed ID: 35095804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatible fungal chitosan encapsulated phytogenic silver nanoparticles enhanced antidiabetic, antioxidant and antibacterial activity.
    Sathiyaseelan A; Saravanakumar K; Mariadoss AVA; Wang MH
    Int J Biol Macromol; 2020 Jun; 153():63-71. PubMed ID: 32112842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced antimicrobial activities of silver-nanoparticle-decorated reduced graphene nanocomposites against oral pathogens.
    Peng JM; Lin JC; Chen ZY; Wei MC; Fu YX; Lu SS; Yu DS; Zhao W
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():10-16. PubMed ID: 27987652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of an electrochemical sensor with graphene aerogel doped with ZrO
    Hou X; Wu W; Zhao F; Xie W; Yang Q
    Mikrochim Acta; 2021 Feb; 188(3):86. PubMed ID: 33587171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green synthesis of graphene oxide sheets decorated by silver nanoprisms and their anti-bacterial properties.
    Zhang D; Liu X; Wang X
    J Inorg Biochem; 2011 Sep; 105(9):1181-6. PubMed ID: 21708103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voltammetric studies of Azathioprine on the surface of graphite electrode modified with graphene nanosheets decorated with Ag nanoparticles.
    Asadian E; Iraji Zad A; Shahrokhian S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1098-104. PubMed ID: 26478409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective killing of bacteria under blue-light irradiation promoted by green synthesized silver nanoparticles loaded on reduced graphene oxide sheets.
    Caires CSA; Farias LAS; Gomes LE; Pinto BP; Gonçalves DA; Zagonel LF; Nascimento VA; Alves DCB; Colbeck I; Whitby C; Caires ARL; Wender H
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110984. PubMed ID: 32487400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of magnesium oxide and zinc oxide nanoparticles against multi-drug-resistance Mycobacterium tuberculosis.
    Yaghubi Kalurazi T; Jafari A
    Indian J Tuberc; 2021 Apr; 68(2):195-200. PubMed ID: 33845951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
    Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
    Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
    Kushwaha K; Dwivedi H
    Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.